Indian J Pharm Close
 

Figure 5: The antiangiogenic activity of SLs on blood vessel outgrowth in ex vivo rat aorta rings. The rings were treated with (a) 0.5% DMSO, (b) 6 μg/mL of SLs, (c) 12 μg/mL of SLs, (d) 25 μg/mL of SLs, (e) 50 μg/mL of SLs, (f) 100 μg/mL of SLs, and (g) 100 μg/mL of suramin as positive control. SLs = Sophorolipids, SD = Standard deviation, DMSO = Dimethyl sulfoxide, ns = Not significant

Figure 5: The antiangiogenic activity of SLs on blood vessel outgrowth in <i>ex vivo</i> rat aorta rings. The rings were treated with (a) 0.5% DMSO, (b) 6 μg/mL of SLs, (c) 12 μg/mL of SLs, (d) 25 μg/mL of SLs, (e) 50 μg/mL of SLs, (f) 100 μg/mL of SLs, and (g) 100 μg/mL of suramin as positive control. SLs = Sophorolipids, SD = Standard deviation, DMSO = Dimethyl sulfoxide, ns = Not significant